[TNF induction in the serum and ascites of a gastric cancer patient treated with OK-432].
A 73-year-old female was diagnosed as having gastric cancer (undifferentiated adenocarcinoma), and received gastrojejunal anastomosis as an initial treatment. One year after the operation, she was readmitted to our hospital with the complaint of fullness in her stomach. Physical examination revealed a palpable mass in the epigastric region and ascites. An attempt to induce endogenous TNF was made using OK-432. Four doses of OK-432 (10 KE) were administered intraperitoneally every other day. Seven days after the last administration of OK-432 (10 KE), OK-432 (50 KE) was given at the same site to induce TNF. At 1.5h after the injection of OK-432 (50 KE), 20.8 U/ml and 8.1 U/ml of TNF activity could be detected respectively in the serum and ascites. This is the first report describing the induction of TNF in a cancer patient.
D000230:Adenocarcinoma / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D000368:Aged; D001202:Ascitic Fluid / Q000378:metabolism*; D001688:Biological Products / Q000627:therapeutic use*; D005260:Female; D006023:Glycoproteins / Q000032:analysis* / Q000097:blood; D006801:Humans; D010844:Picibanil / Q000627:therapeutic use*; D013274:Stomach Neoplasms / Q000378:metabolism* / Q000473:pathology / Q000628:therapy; D014409:Tumor Necrosis Factor-alpha
D001688:Biological Products; D006023:Glycoproteins; D014409:Tumor Necrosis Factor-alpha; D010844:Picibanil